Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections

Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections

US Patent 10913779 · Granted Feb 9, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclin G1 inhibitors and related methods of treating cancer2024
Cyclin G1 inhibitors and related methods of treating cancer2024
Cyclin G1 inhibitors and related methods of treating cancer2022
Cyclin G1 inhibitors and related methods of treating cancer2022
Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion2022
Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion2022
Polypeptide targeting aptamers for characterization, capture, and clinical manag2021
Polypeptide targeting aptamers for characterization, capture, and clinical manag2021
Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion2019
Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion2019
Pathotropic targeted gene delivery system for cancer and other disorders2015
Pathotropic targeted gene delivery system for cancer and other disorders2015